Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET END USER COVERAGE GRID
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: REGULATIONS
5.1 REGULATION IN THE UNITED STATES:
5.2 GOVERNING REGULATIONS:
5.3 CPT CODES:
5.4 PRACTITIONER ELIGIBILITY:
5.5 PATIENT ELIGIBILITY:
5.6 REQUIREMENTS:
5.7 REGULATIONS IN EUROPE:
5.8 NATIONAL STRATEGY AND LEAD ORGANIZATIONS FOR HEALTHCARE SERVICES IN EUROPE:
5.9 DATA PRIVACY PROTECTION IN EUROPE:
5.1 REGULATIONS IN INDIA:
5.11 RELEVANT ACTS FOR THIS FRAMEWORK:
5.12 DATA PRIVACY PROTECTION IN INDIA:
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES
6.1.2 GROWING GERIATRIC POPULATION
6.1.3 RISING PER CAPITA INCOME
6.1.4 ADVANCEMENT IN HEALTHCARE INFRASTRUCTURE AND INITIATIVE ACTIVITIES BY GOVERNMENT ORGANIZATION
6.2 RESTRAINTS
6.2.1 HIGH COST OF SERVICES
6.2.2 SECURITY CONCERNS WITH CLOUD-BASED SOLUTIONS
6.3 OPPORTUNITIES
6.3.1 SURGE IN NOVEL TECHNOLOGICAL ADVANCEMENTS
6.3.2 RISING HEALTHCARE EXPENDITURE
6.3.3 INCREASED REIMBURSEMENT POLICIES
6.3.4 RISING DISEASE MANAGEMENT PROGRAMS
6.4 CHALLENGE
6.4.1 LACK OF ACCESSIBILITY
7 IMPACT OF COVID-19 ON THE MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET
7.1 IMPACT ON PRICE
7.2 IMPACT ON DEMAND
7.3 STRATEGIC DECISIONS OF GOVERNMENT AND MANUFACTURERS
7.4 CONCLUSION
8 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE
8.1 OVERVIEW
8.2 SOLUTION
8.3 SERVICES
9 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE
9.1 OVERVIEW
9.2 ON PREMISE SOLUTION
9.3 WEB BASED SOLUTION
9.4 CLOUD BASED SOLUTION
10 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICES TYPE
10.1 OVERVIEW
10.2 IMPLEMENTATION SERVICES
10.3 CONSULTING SERVICES
10.4 EDUCATION SERVICES
10.5 OTHERS
11 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION
11.1 OVERVIEW
11.2 CARDIOVASCULAR DISEASES (CVD)
11.3 DIABETES
11.4 CHRONIC OBSTRUCTIVE PULMONARY DISORDERS (COPD)
11.5 ASTHMA
11.6 ARTHRITIS
11.7 CANCER
11.8 OTHERS
12 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER
12.1 OVERVIEW
12.2 HEALTHCARE PROVIDERS
12.2.1 HOSPITALS, PHYSICIAN GROUPS, INTEGRATED DELIVERY
12.2.2 DIAGNOSTIC & IMAGING CENTERS
12.2.3 AMBULATORY CARE CENTERS
12.2.4 HOME HEALTHCARE AGENCIES, NURSING HOMES & ASSISTED LIVING FACILITIES
12.2.5 OTHERS
12.3 HEALTHCARE PAYERS
12.3.1 PUBLIC PAYERS
12.3.2 PRIVATE PAYERS
12.4 OTHERS
13 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET BY REGION
13.1 MIDDLE EAST AND AFRICA
13.1.1 SOUTH AFRICA
13.1.2 SAUDI ARABIA
13.1.3 U.A.E.
13.1.4 ISRAEL
13.1.5 EGYPT
13.1.6 REST OF MIDDLE EAST & AFRICA
14 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
15 SWOT ANALYSIS
16 COMPANY PROFILES
16.1 IBM CORPORATION
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 SERVICE PORTFOLIO
16.1.5 RECENT DEVELOPMENTS
16.2 KONINKLIJKE PHILIPS N.V.
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENTS
16.3 COGNIZANT
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENTS
16.4 ALLSCRIPTS HEALTHCARE, LLC
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 SOLUTION PORTFOLIO
16.4.5 RECENT DEVELOPMENTS
16.5 ALTRUISTA HEALTH
16.5.1 COMPANY SNAPSHOT
16.5.2 SOLUTION PORTFOLIO
16.5.3 RECENT DEVELOPMENTS
16.6 CASENET, LLC
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT & SERVICE PORTFOLIO
16.6.3 RECENT DEVELOPMENTS
16.7 CEDAR GATE TECHNOLOGIES
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 RECENT DEVELOPMENT
16.8 CLIEXA, INC.
16.8.1 COMPANY SNAPSHOT
16.8.2 SOLUTION PORTFOLIO
16.8.3 RECENT DEVELOPMENTS
16.9 EPIC SYSTEMS CORPORATION
16.9.1 COMPANY SNAPSHOT
16.9.2 SERVICE PORTFOLIO
16.9.3 RECENT DEVELOPMENT
16.1 EXLSERVICE HOLDINGS, INC.
16.10.1 COMPANY SNAPSHOT
16.10.2 REVENUE ANALYSIS
16.10.3 SERVICE PORTFOLIO
16.10.4 RECENT DEVELOPMENTS
16.11 HEALTH CATALYST
16.11.1 COMPANY SNAPSHOT
16.11.2 REVENUE ANALYSIS
16.11.3 PRODUCT PORTFOLIO
16.11.4 RECENT DEVELOPMENT
16.12 HINDUJA MIDDLE EAST AND AFRICA SOLUTIONS LTD.
16.12.1 COMPANY SNAPSHOT
16.12.2 REVENUE ANALYSIS
16.12.3 PRODUCT PORTFOLIO
16.12.4 RECENT DEVELOPMENTS
16.13 INFOSYS LIMITED
16.13.1 COMPANY SNAPSHOT
16.13.2 REVENUE ANALYSIS
16.13.3 SOLUTION PORTFOLIO
16.13.4 RECENT DEVELOPMENTS
16.14 MEDECISION
16.14.1 COMPANY SNAPSHOT
16.14.2 SOLUTION PORTFOLIO
16.14.3 RECENT DEVELOPMENT
16.15 MINES & ASSOCIATES, INC.
16.15.1 COMPANY SNAPSHOT
16.15.2 PRODUCT PORTFOLIO
16.15.3 RECENT DEVELOPMENT
16.16 NXGN MANAGEMENT, LLC
16.16.1 COMPANY SNAPSHOT
16.16.2 REVENUE ANALYSIS
16.16.3 PRODUCT PORTFOLIO
16.16.4 RECENT DEVELOPMENTS
16.17 PEGASYSTEMS INC.
16.17.1 COMPANY SNAPSHOT
16.17.2 PRODUCT PORTFOLIO
16.17.3 RECENT DEVELOPMENTS
16.18 SCIENCESOFT USA CORPORATION
16.18.1 COMPANY SNAPSHOT
16.18.2 INDUSTRY PORTFOLIO
16.18.3 RECENT DEVELOPMENTS
16.19 TCS HEALTHCARE TECHNOLOGIES
16.19.1 COMPANY SNAPSHOT
16.19.2 SERVICE PORTFOLIO
16.19.3 RECENT DEVELOPMENTS
16.2 VIVIFY HEALTH, INC.
16.20.1 COMPANY SNAPSHOT
16.20.2 SOLUTION PORTFOLIO
16.20.3 RECENT DEVELOPMENTS
16.21 WELLSKY
16.21.1 COMPANY SNAPSHOT
16.21.2 PRODUCT PORTFOLIO
16.21.3 RECENT DEVELOPMENTS
16.22 ZEOMEGA
16.22.1 COMPANY SNAPSHOT
16.22.2 PRODUCT PORTFOLIO
16.22.3 RECENT DEVELOPMENTS
17 QUESTIONNAIRE
18 RELATED REPORTS
List of Table
TABLE 1 NUMBER OF PEOPLE WITH DIABETES AMONG 20–79 YEARS OLD (IN MILLION)
TABLE 2 NEW CANCER CASES FOR AGE 85+ IN THE U.S.
TABLE 3 PER CAPITA AMOUNTS: THE UNITED STATES (1960–2017)
TABLE 4 PRICES OF ESSENTIAL CHRONIC DISEASE MANAGEMENT SOLUTIONS
TABLE 5 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 6 MIDDLE EAST AND AFRICA SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 MIDDLE EAST AND AFRICA SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 8 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)
TABLE 9 MIDDLE EAST AND AFRICA ON PREMISE SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 MIDDLE EAST AND AFRICA WEB BASED SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 MIDDLE EAST AND AFRICA CLOUD BASED SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICES TYPE, 2019-2028 (USD MILLION)
TABLE 13 MIDDLE EAST AND AFRICA IMPLEMENTATION SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 14 MIDDLE EAST AND AFRICA CONSULTING SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 MIDDLE EAST AND AFRICA EDUCATION SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 MIDDLE EAST AND AFRICA EDUCATION SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 18 MIDDLE EAST AND AFRICA CARDIOVASCULAR DISEASES (CVD) IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 19 MIDDLE EAST AND AFRICA DIABETES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION 2019-2028 (USD MILLION)
TABLE 20 MIDDLE EAST AND AFRICA CHRONIC OBSTRUCTIVE PULMONARY DISORDERS (COPD) IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 MIDDLE EAST AND AFRICA ASTHMA IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 MIDDLE EAST AND AFRICA ARTHRITIS IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 MIDDLE EAST AND AFRICA CANCER IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 MIDDLE EAST AND AFRICA OTHERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 25 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 26 MIDDLE EAST AND AFRICA HEALTHCARE ROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 MIDDLE EAST AND AFRICA HEALTHCARE ROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 28 MIDDLE EAST AND AFRICA HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 MIDDLE EAST AND AFRICA HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 30 MIDDLE EAST AND AFRICA OTHERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 31 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 32 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 33 MIDDLE EAST AND AFRICA SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)
TABLE 34 MIDDLE EAST AND AFRICA SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 35 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 36 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 37 MIDDLE EAST AND AFRICA HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 38 MIDDLE EAST AND AFRICA HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 39 SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 40 SOUTH AFRICA SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)
TABLE 41 SOUTH AFRICA SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 42 SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 43 SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 44 SOUTH AFRICA HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 45 SOUTH AFRICA HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 46 SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 47 SAUDI ARABIA SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)
TABLE 48 SAUDI ARABIA SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 49 SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 50 SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 51 SAUDI ARABIA HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 52 SAUDI ARABIA HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 53 U.A.E. CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 54 U.A.E. SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)
TABLE 55 U.A.E. SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 56 U.A.E. CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 57 U.A.E. CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 58 U.A.E. HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 59 U.A.E. HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 60 ISRAEL CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 61 ISRAEL SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)
TABLE 62 ISRAEL SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 63 ISRAEL CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 64 ISRAEL CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 65 ISRAEL HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 66 ISRAEL HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 67 EGYPT CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 68 EGYPT SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)
TABLE 69 EGYPT SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 70 EGYPT CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 71 EGYPT CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 72 EGYPT HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 73 EGYPT HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 74 REST OF MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
List of Figure
FIGURE 1 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: MULTIVARIATE MODELLING
FIGURE 7 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: DBMR MARKET POSITION GRID
FIGURE 9 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: MARKET END USER COVERAGE GRID
FIGURE 11 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: SEGMENTATION
FIGURE 12 GROWING GERIATRIC POPULATION IS EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 13 SOLUTION SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET IN 2021 & 2028
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGE OF MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET
FIGURE 15 PREVALENCE OF CHRONIC DISEASES
FIGURE 16 AGING POPULATION IN THE WORLD (IN MILLIONS)
FIGURE 17 NORTH AMERICA AGING POPULATION (IN MILLIONS)
FIGURE 18 EUROPE AGING POPULATION (IN MILLIONS)
FIGURE 19 ASIA-PACIFIC AGING POPULATION (IN MILLIONS)
FIGURE 20 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY TYPE, 2020
FIGURE 21 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY TYPE, 2019-2028 (USD MILLION)
FIGURE 22 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY TYPE, CAGR (2021-2028)
FIGURE 23 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY TYPE, LIFELINE CURVE
FIGURE 24 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY SOLUTION TYPE, 2020
FIGURE 25 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY SOLUTION TYPE, 2019-2028 (USD MILLION)
FIGURE 26 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY SOLUTION TYPE, CAGR (2021-2028)
FIGURE 27 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY SOLUTION TYPE, LIFELINE CURVE
FIGURE 28 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY SERVICES TYPE, 2020
FIGURE 29 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY SERVICES TYPE, 2019-2028 (USD MILLION)
FIGURE 30 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY SERVICES TYPE, CAGR (2021-2028)
FIGURE 31 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY SERVICES TYPE, LIFELINE CURVE
FIGURE 32 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY DISEASE INDICATION, 2020
FIGURE 33 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY DISEASE INDICATION, 2019-2028 (USD MILLION)
FIGURE 34 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY DISEASE INDICATION, CAGR (2021-2028)
FIGURE 35 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY DISEASE INDICATION, LIFELINE CURVE
FIGURE 36 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY END USER, 2020
FIGURE 37 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY END USER, 2019-2028 (USD MILLION)
FIGURE 38 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY END USER, CAGR (2021-2028)
FIGURE 39 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY END USER, LIFELINE CURVE
FIGURE 40 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: SNAPSHOT (2020)
FIGURE 41 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY COUNTRY (2020)
FIGURE 42 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY COUNTRY (2021 & 2028)
FIGURE 43 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY COUNTRY (2020 & 2028)
FIGURE 44 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY TYPE (2021-2028)
FIGURE 45 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: COMPANY SHARE 2020 (%)
